Caplin Point Nears Ex-Dividend Date: Act Fast for Payout
Caplin Point Labs (NSE:CAPLIPOINT) will soon trade ex-dividend. Investors must act quickly before the record date to receive dividends. Source: Simply Wall Street
Stock news timeline · CAPLIPOINT
Caplin Point Labs
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
- Timeline updates
- 5
- Bullish
- 1
- Neutral
- 3
- Bearish
- 1
- Active days
- 4
News timeline
Showing 5 of 5 updates · Newest first
No matching updates
Change the keyword or sentiment above, then click Apply.
Monday, 14 Sep 20261 update
Tuesday, 01 Sep 20261 update
Caplin Subsidiary Gets Colombia GMP Nod for Oncology Drugs
Caplin Point's subsidiary gets GMP compliance from Colombia's INVIMA for oncology drugs. Certification covers sterile/non-sterile drugs; GMP certificate expected soon. Source: ScoutQuest
Monday, 24 Aug 20262 updates
Hexaware Gains 6% on AI Update; Stock Down 26% YTD
Hexaware Tech shares rose 6% after AI Day update; stock down 26% YTD, trading at 7.85x 10-day avg. Vishal Mega Mart shares rose 9% on stock options grant; down 18% YTD, trading at 4.63x 10-day avg. Apollo Tyres rose 3% after UBS upgraded to 'Buy' with ₹590 target. Caplin Point fell 2% post-US FDA Form 483; down 39% YTD. Source: CNBC TV 18
USFDA Observations Hit Caplin, Natco; Jubilant Gains on New Approval
USFDA issued 10 observations to Caplin Point, 4 to Natco Pharma, and 1 to Aurobindo Pharma post inspections. Jubilant Pharmova's US arm received approval for a new product line. Shares of all 4 pharma firms saw varied movements. Source: CNBC TV 18
Sunday, 23 Aug 20261 update
RIL Ventures into Chemicals, Agri; AGM Clears Key Resolutions
RIL expands its portfolio into chemicals/agriculture, AGM approves major resolutions. FDA observations impact Caplin, NATCO, Choksi; Mobile & EMS stocks gain from govt scheme. Source: CNBC TV 18